- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05423353
Comparative Effects of Paraffin Bath Therapy and ESWT in Patients With De Quervain Tenosynovitis
November 28, 2022 updated by: Volkan Şah, Yuzuncu Yıl University
Comparative Effects of Paraffin Bath Therapy and Extracorporeal Shock Wave Therapy on Pain and Hand Functions in Patients With De Quervain Tenosynovitis
There is no study in the literature comparing both paraffin bath therapy and Extracorporeal Shock Wave Therapy (ESWT) in the treatment of patients with De Quervain Tenosynovitis.
The aim of this study is performing this comparison.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
70
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Van, Turkey
- Yuzuncu Yil University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
16 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Being 18 years or older
- Meeting De Quervain diagnostic criteria
- Not having applied any physical therapy modality to the hand-wrist in the last 1 month
- Not using pain medication in the last 1 month,
- Not using local anesthetics or steroid injections on the hand-wrist in the last 3 months
- Have received written consent to participate in the study, and have come to the last control at the 6th week.
Exclusion Criteria:
- Neurological diseases (especially neuropathies),
- Malignancy,
- Rheumatological diseases
- Pregnancy
- History of hand/wrist fracture or surgery
- Hand/wrist trauma in the last 1 month
- Coagulation disorder diseases
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Paraffin Bath Therapy
Paraffin bath therapy is a physical therapy method that can create a temperature increase of 7.5 °C in the joint capsule and 4.5 °C in the muscle.
|
Device named 'Fizyowax 1300' (Fizyomed, Turkey).
|
Active Comparator: Extracorporeal Shock Wave Therapy
Extracorporeal shock wave therapy (ESWT) is a noninvasive treatment that involves delivery of shock waves to injured soft tissue to reduce pain and promote healing.
|
Device named 'Elettronica Pagani,Italy' and will be used with radial probe.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Visual Analogue Scale (VAS)
Time Frame: at baseline (before the treatment)
|
patient's self-assessment of pain, in the range of 0 to 10, higher scores mean a worse
|
at baseline (before the treatment)
|
Visual Analogue Scale (VAS)
Time Frame: 2 weeks after baseline (at the end of treatment)
|
patient's self-assessment of pain, in the range of 0 to 10, higher scores mean a worse
|
2 weeks after baseline (at the end of treatment)
|
Visual Analogue Scale (VAS)
Time Frame: 6 weeks after baseline (one month after the end of treatment)
|
patient's self-assessment of pain, in the range of 0 to 10, higher scores mean a worse
|
6 weeks after baseline (one month after the end of treatment)
|
Duruöz Hand Index (DHI)
Time Frame: at baseline (before the treatment)
|
Duruöz Hand Index (DHI) is a functional disability scale that can be used successfully to assess the functional disability with different hand arthropathies.
It consists of 18 items that evaluate hand and wrist activities.
The answers are evaluated on a 6-level (0-5) Likert scale and the total score ranges from 0 to 90.
|
at baseline (before the treatment)
|
Duruöz Hand Index (DHI)
Time Frame: 2 weeks after baseline (at the end of treatment)
|
Duruöz Hand Index (DHI) is a functional disability scale that can be used successfully to assess the functional disability with different hand arthropathies.
It consists of 18 items that evaluate hand and wrist activities.
The answers are evaluated on a 6-level (0-5) Likert scale and the total score ranges from 0 to 90.
|
2 weeks after baseline (at the end of treatment)
|
Duruöz Hand Index (DHI)
Time Frame: 6 weeks after baseline (one month after the end of treatment)
|
Duruöz Hand Index (DHI) is a functional disability scale that can be used successfully to assess the functional disability with different hand arthropathies.
It consists of 18 items that evaluate hand and wrist activities.
The answers are evaluated on a 6-level (0-5) Likert scale and the total score ranges from 0 to 90.
|
6 weeks after baseline (one month after the end of treatment)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
July 25, 2022
Primary Completion (Actual)
September 5, 2022
Study Completion (Actual)
October 19, 2022
Study Registration Dates
First Submitted
June 14, 2022
First Submitted That Met QC Criteria
June 14, 2022
First Posted (Actual)
June 21, 2022
Study Record Updates
Last Update Posted (Actual)
November 29, 2022
Last Update Submitted That Met QC Criteria
November 28, 2022
Last Verified
November 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Van YYÜ School of Medicine
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on De Quervain Disease
-
Riphah International UniversityRecruitingDe Quervain SyndromePakistan
-
Cairo UniversityNot yet recruiting
-
University of California, DavisRecruitingDe Quervain TenosynovitisUnited States
-
The University of Hong KongCompleted
-
NYU Langone HealthCompletedde Quervain's DiseaseUnited States
-
National University Hospital, SingaporeNot yet recruitingDe Quervain Syndrome
-
Shin Kong Wu Ho-Su Memorial HospitalCompleted
-
Hüma Bölük ŞenlikciCompletedEvaluation of Effectiveness of Local Anesthetic Injection in Patients With De Quervain TenosynovitisDe Quervain DiseaseTurkey
-
Velammal Medical College Hospital and Research...Completed
-
University Hospital, Strasbourg, FranceNot yet recruiting
Clinical Trials on Paraffin Bath Therapy
-
Riphah International UniversityRecruiting
-
Yuzuncu Yıl UniversityCompleted
-
Riphah International UniversityCompletedKnee Pain ChronicPakistan
-
Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical...National Science Council, TaiwanCompleted
-
Fondazione Salvatore MaugeriCompletedChronic Obstructive Pulmonary Disease (COPD)Italy
-
University of Nove de JulhoUnknown
-
Paracelsus Harz Clinic Bad Suderode.Completed
-
Bakirkoy Dr. Sadi Konuk Research and Training HospitalCompletedHand OsteoarthritisTurkey
-
University of Sao PauloUnknown